Six Lawsuits Filed Against Humira Maker

Pharma Company Accused of Using Legal Tricks to Squash Generic Version Last October, we wrote about the tactics used by pharma company AbbVie to artificially extend its patents on its billion-dollar drug Humira. Now six groups are filing lawsuits against AbbVie for “anticompetitive conduct.” Humira is a rheumatoid-arthritis and gut-disorders drug that enjoys sales of …

Read moreSix Lawsuits Filed Against Humira Maker

World’s biggest-selling drug company cheats competitors and consumers as they extend their exclusive right to sell Humira

The makers of the world’s biggest-selling drug cheat competitors and consumers as they extend their exclusive right to sell Humira. Humira is a rheumatoid-arthritis and gut-disorders drug that enjoys sales of around $18 billion a year. Last Tuesday, one of its patents was set to expire. When a drug’s patent expires, generic manufacturers are free …

Read moreWorld’s biggest-selling drug company cheats competitors and consumers as they extend their exclusive right to sell Humira